Personal profile


Dr Ing Soo Tiong is a clinical haematologist consulting from Eastern Haematology Oncology Group.

He graduated from the University of Otago and completed his Basic Physician Training in Dunedin, New Zealand. He joined Alfred Hospital (2016) as the Leukaemia Fellow, awarded the HSANZ New Investigator Scholarship for 2017, and completed Haematology Advance Training in 2017 with dual Fellowships of the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia.

He is undertaking a part-time research higher degree at Alfred Hospital/Monash University. His interests are myeloid malignancies (acute leukaemias, myelodysplastic syndromes and myeloproliferative neoplasms), but would welcome any malignant and non-malignant haematological condition. He is also active in clinical trial developments, working to translate scientific breakthroughs and seek treatment options for patients he treats.

Ing-Soo is the medical lead for Acute Lymphoblastic Leukaemia at the Austin Hospital.

Other appointments: Alfred Hospital (Clinical Haematologist), Peter MacCallum Cancer Centre (Laboratory Haematologist).

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research area keywords

  • Haematology
  • Myeloid malignancies
  • Acute leukaemia
  • Myelodysplasia

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or